22 Aug 2026Open access
Upregulation of serum circular RNA FUNDC1 and TNF-α in Behçet’s disease: potential diagnostic biomarkersPublisher siteScientific Reports, Ocular Diseases and Behçet’s Syndrome
UniversitiesMarwa Kamel
Active, last published 2026
In cancer-related molecular mechanisms research
Marwa
Kamel
Scholar“Research focused on Cancer-related molecular mechanisms research and adjacent fields.”
Helwan University
Claim Your Profile1
H-index
2
Citations
Marwa has not officially claimed their profile. If you are Marwa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
arwa Kamel is a researcher working on Cancer-related molecular mechanisms research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Marwa's work has been cited 2 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cancer-related molecular mechanisms research×2Ocular Diseases and Behçet’s Syndrome×1
04 · Where I am
Affiliations
Affiliation on published researchHelwan UniversityDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works1 Nov 2024Open access1cites
Downregulation of lncRNA-MALAT1, Altered Immunohistochemical Expression of Cyclin D1 Protein and E-Cadherin Protein in Correlation to Meningioma GradesPublisher siteAsian Pacific Journal of Cancer Prevention, Study of Mite Species
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Marwa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you